David Murcott is listed as an executive officer, director, and promoter on 2 SEC Form D filings by 2 issuers between Dec 2018 and Feb 2019: RealTime Laboratories, Inc. (Carrollton, TX — other health care — 2019; $140K reported sold to 4 investors) and MycoDART, Inc. (Carrollton, TX — biotechnology — 2018; $30K reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter. Across those companies the filings report $170K sold in total.
Listed alongside Jeffrey Hooper (2 shared filings) and Vincent Bolton (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
All 2 issuers belong to the sponsor group Mycodart (2 issuers, $170K reported sold, 2018–2019).
What this means A sponsor group is one team that sets up a new company for each deal. Mycodart has 2 companies on file and $170K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for David Murcott and found 5 differences: David Murcott appears on 2 deals that stopped filing before reaching their target; Form D filed 40 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.